News

Solid Biosciences Inc.: Solid Biosciences Announces FDA IND and Health Canada CTA Approval for First-in-Class Cardiac Gene Therapy to Treat Catecholaminergic Polymorphic ...
SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Design ...
BMJ4d
Stereotactic arrhythmia radioablation in patients with refractory ventricular tachycardia: a systematic review and meta-analysis
Background Stereotactic arrhythmia radioablation (STAR) is a novel, non-invasive treatment for therapy-refractory ventricular ... died during follow-up (table 2). Heart failure was the most frequently ...
Onlymyhealth on MSN6d
Maze Procedure For Irregular Heartbeats: How It Works, Benefits, And Recovery
Atrial fibrillation (Afib) is one of the most common heart rhythm disorders, affecting millions worldwide. It occurs when the ...